ir achillion.com

Investors Achillion Pharmaceuticals

The Investor Relations website contains information about Achillion Pharmaceuticals business for stockholders, potential investors, and financial analysts.
traffic

OVERVIEW

The web site ir.achillion.com currently has an average traffic ranking of zero (the smaller the more traffic). We have parsed twenty-one pages inside the domain ir.achillion.com and found two websites interfacing with ir.achillion.com. There is three social networking sites retained by this website.
Pages Parsed
21
Links to this site
2
Social Links
3

IR.ACHILLION.COM TRAFFIC

The web site ir.achillion.com has seen varying amounts of traffic for the whole of the year.
Traffic for ir.achillion.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.achillion.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.achillion.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

WHAT DOES IR.ACHILLION.COM LOOK LIKE?

Desktop Screenshot of ir.achillion.com Mobile Screenshot of ir.achillion.com Tablet Screenshot of ir.achillion.com

IR.ACHILLION.COM SERVER

Our crawlers observed that a lone page on ir.achillion.com took three hundred and ninety-nine milliseconds to stream. Our web crawlers could not detect a SSL certificate, so therefore our crawlers consider ir.achillion.com not secure.
Load time
0.399 sec
SSL
NOT SECURE
IP
206.200.251.19

SERVER SOFTWARE AND ENCODING

We revealed that this website is employing the Microsoft-IIS/8.5 server.

SITE TITLE

Investors Achillion Pharmaceuticals

DESCRIPTION

The Investor Relations website contains information about Achillion Pharmaceuticals business for stockholders, potential investors, and financial analysts.

PARSED CONTENT

The web site ir.achillion.com has the following on the site, "Rooted in the myth of Achilles, the name of Achillion refers to the brave warrior committed to a cause as well as the companys mission to combat diseases by identifying and exploiting their unique vulnerabilities." I noticed that the webpage also said " Achillion to Present at the Barclays Global Healthcare Conference." They also said " View all press releases . Mar 15, 2018 at 1115 AM ET. Barclays Global Healthcare Conference 2018."

SEE SIMILAR DOMAINS

Acorda Therapeutics Inc - Investors

Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Investor Overview - Active Power Investors Relations

Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Active Power, Inc. Active Power to Present at 43rd An.

Activision Blizzard, Inc. Investor Relations

is the largest and most profitable western interactive entertainment publishing company. It develops and publishes some of the most successful and beloved entertainment franchises in any medium, including. Call of Duty Online,. Activision Brings Strongest Ever Line-up to Gamescom 2015. Activision Blizzard Second Quarter Calendar 2015 Results Conference Call.

Adept Technology, Inc. - Investor Relations

Quotes delayed at least 20 minutes. The Company has been featured in several publications including Fortune, Inc. , Business Week, Forbes ASAP, Red Herring, Industry Week. And The New York Times. Adept Technology will be the global leader in the manufacturing, marketing and innovation of robotics, vision and motion control products for automated material handling and assembly. Click here for 2014 Proxy information.